Lac-Phe (N-lactoyl-phenylalanine) is not a traditional peptide but a small-molecule conjugate of lactate and phenylalanine, produced enzymatically by CNDP2 (cytosolic nonspecific dipeptidase 2) during and after vigorous exercise. Identified by Li, Long, Svensson et al. in a landmark 2022 Nature paper as the most robustly exercise-induced blood metabolite across species, Lac-Phe suppresses food intake and reduces adiposity in obese mouse models, establishing a molecular link between exercise-derived lactate signaling and appetite regulation.

Overview

The discovery of Lac-Phe arose from untargeted metabolomics analysis of blood samples collected after exercise in mice, racehorses, and humans. Among hundreds of metabolites measured, Lac-Phe showed the single largest fold-change increase following sprint exercise across all three species. This cross-species conservation -- from rodents to equines to primates -- suggested fundamental biological importance.

Lac-Phe is synthesized when CNDP2 conjugates exercise-produced lactate with the amino acid phenylalanine. The resulting molecule acts as a humoral signal that suppresses feeding behavior and reduces body weight in diet-induced obese mice over chronic administration. Critically, CNDP2 knockout mice lose the exercise-induced appetite suppression phenotype, demonstrating that Lac-Phe production is necessary for exercise to reduce food intake. This places Lac-Phe at the center of a previously unknown exercise-appetite axis.

Unlike traditional peptides (chains of amino acids linked by peptide bonds), Lac-Phe contains a single amino acid conjugated to lactate via an amide bond. Its small molecular weight (~237 g/mol) places it in the metabolite category rather than the peptide category, but its mechanism of action -- humoral signaling from muscle to brain to regulate feeding -- parallels peptide hormone signaling and is highly relevant to metabolic peptide research.

Mechanism of Action

CNDP2-Dependent Biosynthesis

Lac-Phe is produced by CNDP2, a cytosolic metallopeptidase expressed in multiple tissues including immune cells, epithelial cells, and macrophages. During exercise, lactate levels rise sharply in blood and tissues. CNDP2 catalyzes the condensation of intracellular lactate with phenylalanine to form Lac-Phe. This reaction effectively couples exercise intensity (via lactate production) to anorexigenic signaling (via Lac-Phe) (Li et al., 2022).

Interestingly, CNDP2 is highly expressed in macrophages and other immune cells, suggesting that the innate immune system may play an unexpected role in mediating exercise's metabolic effects. Myeloid cell-specific CNDP2 expression appears important for Lac-Phe production in vivo.

Appetite Suppression Pathway

Lac-Phe suppresses food intake through a mechanism that involves signaling to the brain, though the specific receptor and neural circuit have not been fully elucidated. Key observations include:

• Acute administration of Lac-Phe to diet-induced obese (DIO) mice reduces food intake by approximately 50% over 12 hours without affecting locomotor activity or conditioned taste aversion
• Chronic administration (10 days) reduces cumulative food intake, body weight, fat mass, and improves glucose tolerance in DIO mice
• The effect is most pronounced in obese animals and on high-fat diets, with minimal effect on lean mice eating standard chow -- suggesting preferential modulation of hedonic or reward-based feeding
• The brain regions and receptor(s) mediating Lac-Phe's anorexigenic signal remain under active investigation

CNDP2 Knockout Phenotype

CNDP2 whole-body knockout mice provided critical evidence for Lac-Phe's physiological role. These mice:

• Cannot produce Lac-Phe in response to exercise
• Lose the exercise-induced suppression of food intake
• Gain more weight on high-fat diet compared to wild-type controls despite equivalent exercise
• Demonstrate that endogenous Lac-Phe production is required for the appetite-suppressing effects of exercise (Li et al., 2022)

Cross-Species Conservation

Lac-Phe elevation after exercise has been confirmed in:

• Mice: Sprint treadmill exercise produces >10-fold increase in plasma Lac-Phe
• Racehorses: Post-race plasma shows Lac-Phe as the most elevated metabolite
• Humans: Sprint cycling and resistance exercise produce significant Lac-Phe elevation; the magnitude correlates with exercise intensity and lactate production

Reconstitution Calculator

Research

Safety Profile

Lac-Phe is an endogenous metabolite produced naturally during exercise in all studied mammalian species, including humans. Plasma Lac-Phe rises acutely with every bout of vigorous exercise and returns to baseline within hours. This suggests an inherently favorable safety profile for transient exposure.

Considerations for exogenous or chronic administration include:

• Appetite suppression: Excessive or sustained appetite suppression could theoretically cause undernutrition, particularly in lean or metabolically healthy individuals.
• Receptor unknown: Until the Lac-Phe receptor is identified, off-target effects of exogenous administration cannot be fully predicted.
• No human intervention studies: As of current literature, no human clinical trials of exogenous Lac-Phe administration have been conducted.
• Metabolic context: Effects appear strongest in obese/high-fat diet models with minimal impact on lean animals, suggesting a built-in safety margin against excessive appetite suppression in metabolically healthy individuals.

Pharmacokinetic Profile